Men treated for prostate cancer after surgery now have clearer evidence that extending hormone therapy from six months to two ...

Practice-changing perioperative therapy, chemo-free combo for CSPC, reducing cognitive eff ...

In this video, Matthew R. Zibelman, MD, discusses the A-DREAM trial, which found that androgen deprivation therapy ...

If the US FDA approves it, aglatimagene immunotherapy may become the first new therapy for men with localized prostate cancer in the past 2 decades.

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this video, Atish D. Choudhury, MD, PhD, discusses a study of androgen deprivation therapy ...

A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine whether prostate cancers are susceptible to a type of cell death known as ...

For most children, kicking a soccer ball around the backyard is an everyday activity. For 6-year-old Hadley McMahon, it's something her Colorado family once feared they would never see. Hadley, a ...